Campbell & CO Investment Adviser LLC Bristol Myers Squibb CO Transaction History

Campbell & CO Investment Adviser LLC

$1.14 Billion
Q1 2024

A detailed history of Campbell & CO Investment Adviser LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 12,979 shares of BMY stock, worth $525,000. This represents 0.06% of its overall portfolio holdings.

Number of Shares

12,979

Previous 18,320 29.15%

Holding current value

$525,000

Previous $939,000 25.13%

% of portfolio

0.06%

Previous 0.09%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$47.98 - $54.4 $256,261 - $290,550	-5,341 Reduced 29.15%	12,979 $703,000
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $842,679 - $1.01 Million	-17,382 Reduced 48.69%	18,320 $939,000
Q3 2023 Nov 08, 2023	BUY	$57.89 - $64.73 $1.67 Million - $1.87 Million	28,823 Added 419.0%	35,702 $2.07 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $155,452 - $172,605	2,440 Added 54.97%	6,879 $439,000
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $520,883 - $590,799	-7,927 Reduced 64.1%	4,439 $307,000

Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $344,317 - $407,720	-5,028 Reduced 28.91%	12,366 $889,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $816 - $482,401	6,278 Added 56.48%	17,394 $1.24 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $603,835 - $665,033	8,315 Added 296.86%	11,116 $856,000
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $129,046 - $154,738	-2,099 Reduced 42.84%	2,801 $205,000
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $262,787 - $306,348	4,900 New	4,900 $306,000
Q2 2021 Aug 11, 2021	SELL	$61.91 - $67.42 $759,264 - $826,838	-12,264 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $727,745 - $818,499	12,264 New	12,264 $774,000
Q4 2019 Jan 23, 2020	SELL	$49.21 - $64.19 $425,961 - $555,628	-8,656 Closed	0 $0
Q3 2019 Oct 16, 2019	BUY	$42.77 - $50.71 $370,217 - $438,945	8,656 New	8,656 $439,000
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $271,934 - $352,633	-5,577 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$55.19 - $62.25 $307,794 - $347,168	5,577 New	5,577 $346,000
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $247,529 - $284,956	-4,131 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $247,612 - $269,960	4,131	4,131 $253,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Account

Campbell & CO Investment Adviser LLC Bristol Myers Squibb CO Transaction History